Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 792–793 | Cite as

ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases

  • Hop S. Tran Cao
  • Jean-Nicolas VautheyEmail author
ASO Author Reflections
  • 39 Downloads

Notes

Disclosures

Hop S. Tran Cao and Jean-Nicolas Vauthey have no conflicts of interest to disclose.

References

  1. 1.
    Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–59.CrossRefGoogle Scholar
  2. 2.
    Mayo SC, de Jong MC, Bloomston M, et al. Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol. 2011;18(13):3657–65.CrossRefGoogle Scholar
  3. 3.
    Saxena A, Chua TC, Perera M, Chu F, Morris DL. Surgical resection of hepatic metastases from neuroendocrine neoplasms: a systematic review. Surg Oncol. 2012;21(3):e131–41.CrossRefGoogle Scholar
  4. 4.
    Cloyd JM, Omichi K, Mizuno T, et al. Preoperative fluorouracil, doxorubicin, and streptozocin for the treatment of pancreatic neuroendocrine liver metastases. Ann Surg Oncol. 2018;25(6):1709–15.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Surgical OncologyBaylor College of MedicineHoustonUSA
  2. 2.Department of Surgical OncologyUniversity of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations